Established elective healthcare practice in the cosmetic space generating roughly $1.9M annual revenue with adjusted EBITDA near $0.5M, supported by over 39,000 active and historical patient files and attractive cash flow margins. The practice serves a primarily female, African American and Latino patient base across the broader Mid?Atlantic corridor, with about 25% of patients traveling from out of state for procedures.

The business operates an accredited, Medicare-certified outpatient facility and a fully furnished administrative office totaling about 5,000 sq ft under a transferable lease with renewal options. Revenue derives from high-margin physician-performed procedures (around 85% of mix), complemented by non-surgical injectables, GLP?1 weight-loss programs, and recurring management and facility fees. A registered trademark, accreditation, and long-standing participation in regenerative medicine and AI-driven medical imaging research enhance brand value and clinical positioning while reinforcing patient trust.

Patients value the practice’s decades-long reputation for natural outcomes, safety, and education, driving strong repeat usage, word-of-mouth referrals, and excellent online reviews. The owner plans a structured retirement transition, remaining full time for a defined period and then 1–2 days per week in surgical, advisory, or injector roles to ensure continuity. A buyer acquires a turnkey clinical and administrative team, accredited infrastructure, and a defensible brand with meaningful upside from adding another physician to utilize underused procedure-room capacity, leveraging the existing out-of-state draw for geographic expansion, and scaling non-surgical, subscription-like services such as injectables, GLP?1s, and longevity programs through enhanced tech-enabled marketing and virtual consultation workflows.